Metformin: a modulator of bevacizumab activity in cancer? A case report

about

Efficacy of metformin for advanced-stage endometrial cancer: A case report Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

P2860

Q33598291-F52C116D-2D0F-445E-8FD3-3686E1326756 Q52655425-4D3DE532-5C00-4BB5-8E36-A1F965958B3A

P2860

Metformin: a modulator of bevacizumab activity in cancer? A case report

Item

http://www.wikidata.org/entity/Q36214971

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Metformin: a modulator of bevacizumab activity in cancer? A case report

@ast

Metformin: a modulator of bevacizumab activity in cancer? A case report

@en

type

Item

label

Metformin: a modulator of bevacizumab activity in cancer? A case report

@ast

Metformin: a modulator of bevacizumab activity in cancer? A case report

@en

prefLabel

Metformin: a modulator of bevacizumab activity in cancer? A case report

@ast

Metformin: a modulator of bevacizumab activity in cancer? A case report

@en

P1476

Metformin: a modulator of bevacizumab activity in cancer? A case report

@en

P2093

Alessandra Casarin

http://www.w3.org/2001/XMLSchema#string

Camillo Aliberti

http://www.w3.org/2001/XMLSchema#string

Fabio Pomerri

http://www.w3.org/2001/XMLSchema#string

Giovanni Randon

http://www.w3.org/2001/XMLSchema#string

Margherita Nardin

http://www.w3.org/2001/XMLSchema#string

Maria Ornella Nicoletto

http://www.w3.org/2001/XMLSchema#string

P2860

Investigating metformin for cancer prevention and treatment: the end of the beginning

Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A.

LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin

Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.

Metformin use and endometrial cancer survival

Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.

Anti-vascular endothelial growth factor therapy in the era of personalized medicine.

Metformin is associated with improved survival in endometrial cancer.

P304

210-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1080/15384047.2014.1002366

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Indraccolo

Elisabetta Zulato

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271332570

http://www.w3.org/2001/XMLSchema#string

P698

25607951

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

4623111

http://www.w3.org/2001/XMLSchema#string

Metformin: a modulator of bevacizumab activity in cancer? A case report

about

P2860

P2860

Metformin: a modulator of bevacizumab activity in cancer? A case report

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932